I agree with you , not sure if they want to submit in December , probably , we know they have a meeting then..

You slide look good , unfortunately , all of this will not happen in Q1 .2019....

but hopefully in Q3 , and being that they gave them now rolling review , time of approval might not be to much different ..

I really think FDA see the positives in Leronlimab and is working with them...